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Abstract 
High dose rate (HDR) brachytherapy is a radiation treatment technique capable of delivering large dose 
rates to the tumor. Radiation is delivered using remote afterloaders to drive highly active sources 
(commonly 192Ir with an air KERMA strength range between 20 000 and 40 000 U, where 1 U = 1 uGy m2/
h in air) through applicators directly into the patient's prescribed region of treatment. Due to the obvious 
ramifications of incorrect treatment while using such an active source, it is essential that there are 
methods for quality assurance (QA) that can directly and accurately verify the treatment plan and the 
functionality of the remote afterloader. This paper describes the feasibility study of a QA system for HDR 
brachytherapy using a phantom based two-dimensional 11 x 11 epitaxial diode array, named "magic 
phantom." 
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Purpose: High Dose Rate (HDR) Brachytherapy is a radiation treatment technique capable of 
delivering large dose rates to the tumour. Radiation is delivered using remote afterloaders to drive 
highly active sources (commonly 192Ir with an air KERMA strength range between 20000 to 40000 U, 
where 1U = 1 μGy m2/h in air) through applicators directly into the patient’s prescribed region of 15 
treatment. Due to the obvious ramifications of incorrect treatment while using such an active source, it 
is essential that there are methods for quality assurance (QA) that can directly and accurately verify 
the treatment plan and the functionality of the remote afterloader. This paper describes the feasibility 
study of a QA system for HDR brachytherapy using a phantom based two-dimensional 11x11 
epitaxial diode array, named “Magic Phantom”.  20 
Methods: The HDR brachytherapy treatment plan is translated to the phantom with two rows of 10 
(20 in total) HDR source flexible catheters, arranged above and below the diode array “Magic Plate” 
(MP). Four dimensional source tracking in each catheter is based upon a developed fast iterative 
algorithm, utilising the response of the diodes in close proximity to the 192Ir source, sampled at 100 
ms intervals by a fast data acquisition (DAQ) system. Using a 192Ir source in a solid water phantom, 25 
the angular response of the developed epitaxial diodes utilised in the MP and also the variation of the 
MP response as a function of the source-to-detector distance (SDD) were investigated. These response 
data are then used by an iterative algorithm for source dwelling position determination. A 
measurement of the average transit speed between dwell positions was performed using the diodes 
and a fast DAQ. 30 
Results: The angular response of the epitaxial diode showed a variation of 15% within 360°, with two 
flat regions above and below the detector face with less than 5% variation. For SDD distances of 
between 5 and 30 mm the relative response of the epitaxial diodes used in the MP is in good 
agreement (within 8%) with radial dose function measurements found within the TG-43 protocol, 
with SDD of up to 70 mm showing a 40% over response. A method for four dimensional localisation 35 
of the HDR source was developed, allowing the source dwell position to be derived within 0.50 mm 
of the expected position. An estimation of the average transit speed for varying step sizes was 
determined and was found to increase from (12.8 ± 0.3) cm/s up to (38.6 ± 0.4) cm/s for a step size of 
2.5 mm and 50 mm, respectively.  
Conclusions: Our characterisation of the designed QA “Magic Phantom” with MP in realistic HDR 40 
photon fields demonstrates the promising performance for real-time source position tracking in four 
dimensions and measurements of transit times. Further development of this system will allow a full 
suite for QA in HDR brachytherapy and analysis, and for future in-vivo tracking. 
  
I. Introduction 45 
High Dose Rate (HDR) brachytherapy has shown to be beneficial due to its ability to provide a highly 
localised dose in short treatment times. The advantages and disadvantages of this technique have been 
well documented within TG-59 report1. As brachytherapy involves high dose rates (air KERMA 
strength range between 20000 to 40000 U), minimal fractionations and short treatment times, it is 
essential that treatments are delivered with high accuracy, as errors will result in severe 50 
complications2,3.  
While contemporary radiotherapy is very accurate, errors have happened. More than 500 HDR 
accidents (including one death2) have been reported along the entire chain of procedures from source 
packing to delivery of dose3. Although most errors in brachytherapy have been the result of human 
errors, rather than failure of the treatment delivery system and treatment planning, the fast verification 55 
of the remote afterloading units and generated treatment plans are important in a “good” quality 
assurance program. The American Association of Physicists in Medicine ratified that to guarantee a 
good quality assurance program, the medical physicist should be able to accurately measure the 
source position, timing, transit velocity and, ideally, absorbed dose distribution4.  
An ideal system for treatment verification should be able to provide the 3D identification of the dwell 60 
positions, measure the dwell and transit times, and compare in real-time these parameters with the 
treatment planning. In the literature there are several studies that investigate different HDR 
brachytherapy Quality Assurance (QA) approaches. The main goal of the majority of these studies, 
described below, was to develop a method of localising the source dwell positions and measure timing 
patterns. 65 
A pinhole imaging system, coupled with an x-ray fluoroscope and radiographic screen-film was 
developed by Duan et al5. The system has two pinholes placed away from the patient and is used to 
reconstruct the source dwell positions in three dimensions using a triangulation reconstruction 
algorithm. The source was localised within 1 mm and allowed for recording of a HDR treatment by 
the fluoroscopy machine on to a standard VCR video-tape for post-treatment verification. This 70 
method, while able to reconstruct the source position in post-processing of film, relied on the user to 
notice any significant deviations in position via the fluoroscope screen during actual treatment. 
Nakano et al6 proposed the use of diamond detectors for HDR source localisation. The detectors were 
characterised for their use in HDR, and, using a suggested triangulation method with a minimum of 3 
detectors, the source position could be calculated in three dimensions. The intended method would 75 
able to localise the source with an accuracy of 2 mm, according to the authors, within a source to 
detector distance of 1 to 12 cm, based on the dose to SDD fit used. 
A method for using a mobile C-arm fluoroscopy machine to image the check cable at dwell positions 
prior to treatment was investigated by Liu et al7. Verifying by visual inspection, the authors remarked 
that the method is useful for observing gross errors, larger than 1 cm, in dwell positions. 80 
The use of a single flat panel detector for tracking the brachytherapy source has been described by 
Song et al8. The flat panel is coupled with ball bearings (BBs) in a set pattern on a tray, and uses the 
shadows of the BBs to determine the coordinates of the source. The source was stepped within a steel 
applicator, taped to the surface of a plastic slab. The device was capable of determining the position of 
the source with a mean difference of 0.7 mm with a standard deviation of 1.5 mm. While it was noted 85 
that the flat panel used was slow, and required 5 seconds per image acquisition, there are flat panels 
capable of 45 frames per second and with development into the automation of the BB shadow 
recognition there is the possibility of fast source tracking. 
Batic et al9 expanded the idea of pinhole imaging, using silicon pixelated detectors instead of film. 
Two catheters were fixed within a support structure with the detection system at a fixed distance away 90 
in air. It offers the ability to reconstruct the source position from a source to pinhole distance in air of 
40 cm with a precision of about 5 mm. However, this is comparable to the distance between two 
dwelling positions of the HDR source during treatment and is based on the accuracy of the alignment 
of the detectors with the pinholes. Although the readout of these detectors allowed for reconstruction 
within 1 second, giving the possibility of tracking, there was no indication if the detection system was 95 
capable of measuring the timing pattern of the source.  
Rickey et al10 developed a quality check tool for HDR brachytherapy combining the use of 
radiochromic film and photodiodes for determination of the dwell positions and temporal patterns of 
the source within the device’s fixed treatment tube. Readout of the temporal response of the four 
photodiodes gave a resolution of 1 ms for measurements of the dwell times. Dwell position are 100 
reconstructed with an accuracy of 0.5 mm by manual optical inspection and 0.2 mm by a digital post-
processing of the film. The authors state that this method allowed for the verification of the position 
and dwell times of a single catheter in about 6 minutes. Assuming up to 18 catheters for a treatment 
plan, the use of this device would not be recommended for QA within clinics. 
The use of commercial ion chamber arrays, designed for external beam radiotherapy, was investigated 105 
by Manikandan et al11 for HDR source position verification by placing the catheters directly on top of 
the device. The I’matriXX (IBA Dosimetry GmbH, Germany) verified treatment dwell positions with 
a maximum error of 1.8 mm for step sizes larger than 2 cm. It found that due to the large width of 
each ion chamber (approximately 5.8 mm), the device displayed a volume averaging effect and step 
sizes below 1 cm could not be resolved. 110 
The transit dose of a HDR unit was quantified by Fonseca et al12, based upon calculations of the 
instantaneous source speed and a Monte Carlo (MCNP5) simulated transit dose profile. The 
instantaneous source speed, measured using a high resolution optical fiber based detector system13 
was used to give weighting to the simulated transit dose and allow for an accurate calculation of 
transit dose values. The results were verified experimentally using radiochromic film and showed that 115 
the transit component can be significant, reaching up to a few hundred cGy per application.  
Two commercial devices have been developed by Mick Radio-Nuclear Instruments for HDR QA. The 
PermaDoc GC Phantom14 allows for the insertion of a single HDR catheter into the device and the 
source exposes its position as well as centimetre markers onto gafchromic film. This solution verifies 
one catheter at a time and would require digital post processing to determine an accurate position.  120 
The second device, the MultiDoc Phantom15, allows for up to 21 catheters inserted into a phantom, 
where the source can be seen through the catheter, above the phantom. Next to each catheter insert are 
positional markings in 1 mm increments, and the source dwelling and timing is captured by a high 
resolution video camera above the phantom. While capable of source position and timing of up to 21 
catheters, the system relies heavily on the user to perform verification by watching and analysing the 125 
video recording.  
These various studies have shown the potential of several systems for HDR QA but may require large 
and expensive imaging systems and most of them are unable to offer a complete stand-alone real time 
quality assurance solution, capable of fast and accurate source localisation and analysis combined 
with high temporal resolution.  130 
This work presents the feasibility study of a new concept of QA for HDR brachytherapy based on 
“magic plate” (MP) developed at the Centre for Medical Radiation Physics, University of 
Wollongong, Australia. The MP, a 0.5 mm thick Kapton plate with an embedded two dimensional 
silicon diode array, was designed for use in a special portable “magic phantom” for fast pre-treatment 
check of the remote HDR afterloader source dwelling and timing by comparison in real time with the 135 
prescribed treatment plan. It could also be used in-vivo for intra-operative assessment of the source 
position, transit time and dwell time within the body of the patient. The MP has a high response to 
radiation, high radiation hardness, small sensitive volume of each diode for pinpoint measurements, 
large field of view (10x10 cm2) and readout electronics capable of accurate readout of all diodes 
within 100 μs.  140 
This study explores the characterisation of the MP and “magic phantom” for pre-treatment QA system 
in terms of real time identification of dwell time and source positioning and verification of the transit 
timing for different distances between dwelling positions. The system is based on a novel adapted for 
HDR QA 2D diode array, MP, developed at the Centre for Medical Radiation Physics (CMRP), 
University of Wollongong, which was originally designed as a dosimeter for IMRT/VMAT quality 145 
assurance16.  
II. Materials  
Several studies have been carried out examining the use of silicon diodes for dosimetry in 
conventional and intensity-modulated external beam radiotherapy17,18,19,20,21. All these studies agree 
on the selection of p-type silicon detectors as the best candidate for dosimetry of high energy photons 150 
for their high radiation hardness and reproducibility of the response. The MP detector was originally 
designed for IMRT radiation therapy quality assurance. It comprises of an 11x11 array of epitaxial 
silicon p-type diodes embedded into a 0.5 mm thick Kapton carrier (Figure 1). Its specialised 
packaging, using “Drop-in” technology, has been designed to minimise perturbation of the radiation 
field, avoid dose enhancement due to high Z materials and to maximise the flexibility of the detector 155 
to be adaptable to curved shape surfaces such as the human body. MP is 99.8% transparent in a 6 MV 
photon field when used in fluence mode16. 
 
Figure 1 - The magic plate detector array. 
Each diode is a 50 μm thick p-type (100 Ω-cm) Si epitaxial layer grown on a 375 μm thick p+ (0.001 160 
Ω-cm) substrate. Dimensions of each detector are 1.5x1.5x0.375 mm3 with 0.6x0.6x0.05 mm3 
sensitive volume and 10 mm detector pitch. The MP has been pre-irradiated with 60Co gamma 
photons to stabilise diode sensitivity16. MP is readout by a multichannel charge to frequency converter 
preamplifier named TERA06, designed by the Instituto Nazionale di Fisica Nucleare (INFN) – Turin 
Division and University of Turin microelectronics group for readout of pixelated ionisation or strip 165 
chambers for Hadron Therapy22.  
The TERA06 is used in conjunction with a Field Programmable Gate Array (FPGA) module. The 
digital readout and back-end system was designed and developed by the CMRP, and is equipped with 
a custom designed C++ multi-platform user interface, so named “Rad-X DoseView”. It is capable of 
reading out each detector in the MP array with zero dead time over a variable acquisition time 170 
(between 100μs - 100 ms) with real time visualisation and data analysis. 
For pre-treatment verification, the MP based phantom system will be able to assess a complete HDR 
treatment, by verifying the dwell positions and timings, the transit between dwell positions, and the 
integral dose delivered to the MP diodes for the verified treatment. It allows for comparison with a 
plan imported from the treatment planning system that is translated to the “magic phantom” and 175 
would be capable of real time verification providing identification of error on a particular step of 
treatment.  
The MP is sandwiched in a solid water phantom, “magic phantom”, with two insertable rows of 10 
catheter holes, up to 20 in total, to suit the needs of the HDR afterloader and prescribed treatment plan 
as seen in Figure 2. The MP is positioned between the rows of holes and is used to reconstruct in real 180 
time the position of the source within the phantom, moving according to the prescribed treatment 
plan. 
 
Figure 2 - Illustration of the HDR Pre-treatment QA magic phantom with magic plate inserted. 
 185 
Initially, the individual diodes were characterised in terms of their angular response by a 192Ir source 
in a water equivalent plastic phantom. For these tests, the single epitaxial diodes were mounted onto a 
10 mm wide, 25 cm long Kapton carrier with the same packaging process used for MP (“Drop-in” 
technology). The sensor was readout by a single channel fast electrometer named X-Tream. The X-
Tream unit is primarily designed by CMRP as a dosimetry system for Microbeam Radiation Therapy 190 
quality assurance23, and characterised mainly by its high dynamic range (~105) and high sampling rate 
(1 MHz).  
All measurements were taken using the MicroSelectron HDR afterloader (Nucletron, The 
Netherlands) available at the Prince of Wales Hospital, Randwick (Sydney). The 192Ir source activity 
varied during the experimental sessions from 40000 U down to 20000 U and all the measurements 195 
and planning have been normalised the air-kerma strength of the source. In all the experiments, the 
HDR source was driven through the transfer tubes, into a flexible plastic catheter. 
III. Methods 
III.A. Angular Response Measurements 
The intrinsic asymmetric structure of the epitaxial diode of MP and the energy range of the gamma 200 
photons emitted by the 192Ir may result in directional dependence for each detector (Figure 3). To 
predict the angular response of the epitaxial diodes in the MP for any position of the source, it is 
necessary to characterise the angular response of the single diode of the array along both the azimuth 
and polar angles.  
 205 
Figure 3 - Variation of angles of MP sensors (dark grey) with respect to HDR Source (black). 
To measure the azimuth angular response the diode was placed within a rotatable cylindrical phantom 
that was encased in a cubic phantom of 30x30x30 cm3 solid water, to ensure full body scattering 
conditions. A HDR prostate brachytherapy catheter was placed at 20 mm SDD, as seen in Figure 4. 
Initial position (θ = 0°) was taken as when the orientation of the detector’s sensitive volume was 210 
‘face-up’ relative to the source.  
Using a 28000 U 192Ir source, the MicroSelectron HDR brachytherapy afterloader was programmed to 
position the source to a distance of 1240 mm (final dwell position at the end of the catheter) for 45 
seconds at the dwell position and then retract. The system acquired data at 1 MHz sampling frequency 
and averaged it over 10 samples to minimise variance due to electrical and thermal noise. The 215 
cylindrical insert was rotated in a clockwise direction for a total of 180° rotation with measurements 
taken at every 30° increment. There was no need to measure along a full rotation due to the 
rectangular diode design.  
 
Figure 4 - Cross-section view of the set-up for the 
measurement of the azimuth detector response. Sensitive 
volume of the detector in grey. 
 
Figure 5 - Cross-section view of the set-up for the 
measurement of the polar detector response. 
Polar angular response characterisation required the design of a specific phantom where the HDR 
source would move on an arc of radius 5 cm, centred at the detector to minimise the effect of any 220 
variation in the SDD and any anisotropy effects of the source. A schematic diagram of the phantom is 
shown in Figure 5. The detector is placed side on in a groove, machined into the phantom. In this 
orientation, when the source is at the final dwell position of the catheter, the detector sensitive volume 
faces the perpendicular axis of the source at 0°. Stepping the source in 13 mm increments around the 5 
cm arc radius obtains about 15° angle step. The source was driven around an arc of 180°. 225 
III.B. Source-to-Detector Distance Dose Measurements 
Accurate dose verification at regions in the immediate proximity to the source is imperative in HDR 
brachytherapy. Due to the large dose gradients associated with 192Ir source, a slight variation in 
position leads to a large variation in dose. Determination of the position of the source using a 
triangulation algorithm requires knowledge of accurate relative SDD dose response of the diode 230 
measured in a water equivalent phantom, with a diode placed face on relative to the HDR source. 
The MP was used to measure the response of the diode in a solid water phantom with varying SDDs 
from 6 mm to 71 mm, relative to a stationary HDR source along the central axis of the diode, 
perpendicular to the face of the sensitive volume. The catheter was placed at the centre of a 30x30x30 
cm3 solid water phantom and the 28000 U HDR 192Ir source was programmed to dwell directly over 235 
the middle detector of the MP, with the MP placed at different depths in the phantom. 
The diode response was normalised to 100% at 15 mm SDD. This SDD was chosen to minimise the 
effect of uncertainty in experimental setup and energy response of the diode associated with the 
softening of the 192Ir spectra with SDD24. These results used to calculate the radial dose function and 
are compared to the values found within the AAPM TG-43 protocol25. This calculation was 240 
performed to take into account the 1/r2 dependence of the source. 
III.C. HDR Source Tracking using magic plate 
MP is a 2D array of diodes where each detector element is measuring energy deposited by the gamma 
photons or secondary electrons emitted by a source with no directional information. However, the 
radial SDD r can be estimated taking into account the diode response as a function of distance and 245 
angle normalised to the activity of the source. Correlation of the measurements taken by three or more 
detectors can then identify the position of the source in three dimensions using a triangulation method 
based on estimation and iteration26 (Figure 6). This technique requires the accurate characterisation of 
the detector response to 192Ir gamma spectrum in terms of relative SDD dose and angular responses. 
 250 
Figure 6 - Triangulation of the HDR source based on the response of three non collinear detectors. 
A software tool was developed in C++ to calculate the position of the HDR source in 3D using the 
real time response of each detector in MP acquired by the TERA system. As three non-collinear 
detectors are the minimum for localisation of the source, selection of more than three allows for 
redundancy in estimation of the x, y and z coordinates of the source, and inaccuracy reduction. The 255 
MP is an 11x11 array, and every detector can be used for estimating the source position, however, 
only the detector with the highest response and its immediate neighbours (2x2 or 3x3 subset) were 
considered to minimise uncertainty due to lower signal from the detectors at larger distances from the 
source as well as minimise uncertainty with non-isotropic response of the detector and emission of the 
source. The origin of the detector coordinate system is set at the sensor on the bottom left of MP 260 
(Figure 7, point O) that provide coordinate of each detector di on MP.  
 
Figure 7 - HDR Source Triangulation co-ordinate system, z axis is out of page. The xs and zs are constant with the source 
travelling only in the y direction. 
The response of the central diode in the MP per unit source air-kerma strength was measured for 265 
known activity 192Ir source in water with centre of HDR source located 10 mm above the centre of the 
diode under full backscattering conditions. The MP response was normalised prior to this in a 20x20 
cm2 photon field from a 6MV LINAC at a source-to-surface distance of 100 cm in a 30x30x30 cm3 
solid water phantom. The MP was placed at a depth of 10 cm, where the photon field has a flat dose 
profile, verified regularly using an ion chambers as part of the LINAC’s quality checks. 270 
Reproducibility of all diodes before normalization was better than 1%. It is assumed that the response 
of the detector varies linearly with the HDR source strength. 
The HDR 192Ir source is located at position 𝑆(𝑥𝑆,𝑦𝑆, 𝑧𝑆). The data acquisition system acquires a frame 
of the whole MP array. The software tool searches for the highest response within the data set. The 
detector with the highest response is selected to be D1 and the 8 surrounding detectors not all collinear 275 
are also selected, when not considering D1 to be on the edges of MP. Using the response of each 
detector, the detectors distance from the centre of the source can be calculated. 
The response of the i-th detector, Ri, is a function of its distance ri from the HDR source, based upon 
the SDD dose response measured, 𝑅𝑖 = 𝑓(𝑟𝑖). The distance of the source to the detector i, can be then 
calculated by the inverse function 𝑟𝑖 = 𝑓−1(𝑅𝑖), derived from the calculation of the radial dose 280 
function, which was measured for angle θ = 0°. This estimation of distance of the source to the 
detector assumes no angular dependence and is corrected for on further iterations. Based on several 
(at least from three detectors) derived distances ri the source initial position 𝑆′(𝑥𝑠′ ,𝑦𝑠′, 𝑧𝑠′), (Figure 7) in 
the MP frame is estimated. 
 Using the estimated source position, 𝑆′(𝑥𝑠′ ,𝑦𝑠′, 𝑧𝑠′), and the coordinate of the i-th detector 𝐷𝑖(𝑥𝑖 ,𝑦𝑖 , 𝑧𝑖), 285 
the geometrical distance 𝑑𝑖 is calculated. An iterative technique has been devised to find the source 
position by calculating the minimization of the square of the sums of the percentage difference of the 
values of 𝑑𝑖 and 𝑟𝑖 with varying position estimations and taking into account angular response of the 








As the source is assumed to be closest to the detector with the highest response, 𝐷1(𝑥1,𝑦1, 𝑧1), the sum 290 
of the squares is calculated using the first estimation of the source position, 𝑆′(𝑥𝑠′ ,𝑦𝑠′, 𝑧𝑠′) =
𝑆′(𝑥1,𝑦1, 𝑧𝑠′), with 𝑧𝑠′ derived from the equivalence of 𝑟1 and the distance between 𝐷1 and the source 
coordinate estimation. The second and third iterations are performed by changing 𝑥𝑠′  by ±5 mm, and 
then determining which sum of the squares is lower. The method is then repeated with a change in the 
estimation that is half of the previous, until the change is lower than 0.04 mm. The method is then 295 
repeated with changes in the estimation of 𝑦𝑠′.  
This robust method essentially fits the best estimation of the source position to the detectors response. 
The relative angle of each diode to the source is then calculated and corrections are then applied to the 
MP response based upon the angular dependence of each detector. The source position is then re-
estimated by the above method. 300 
Validation of the source tracking method was performed using the afterloader programmed to drive 
the HDR source at 2.5 mm step sizes and with a dwell time of 2 seconds towards the end of the 
catheter. The catheter was placed within a water equivalent plastic phantom and positioned directly 
above the middle column of the MP detectors (x = 50 mm) with the source stepping across the y 
direction. The method was evaluated with MP at a SDD of 10 mm below the catheter’s plane. The 305 
source positions are reconstructed for each acquisition frame of the whole MP using developed 
routines and compared to the input of the afterloader software. 
III.D. HDR source speed measurement using X-Tream System 
Due to the fast acquisition sampling rate of the X-Tream system, up to 1 MHz, it is possible to 
measure the response of a single epitaxial diode (instantaneous dose rate) while the source is in 310 
transit. The diode mounted in a kapton tail as mentioned earlier is placed at the centre of a 30x30x30 
cm3 solid water phantom, with the HDR catheter placed at 5 mm distance from the detector.  
The HDR source is stepped to the first dwell position within the catheter, and is stationary for 5 
seconds. It then moves to the next dwell position, with a measureable time in transit. The source 
remains at the second dwell position for an additional 5 seconds followed by returning to the 315 
afterloader. The step size was varied from 2.5 mm to 50 mm, and the transit time and average speed 
were recorded. Previous evaluations of the transit velocity using direct measurements have shown a 
range been 5.4 to 33.1 cm/s27,28,29 for the same range of step sizes.  
IV. Results 
IV.A. Angular Dependence 320 
The directional dependence of the epitaxial diode response is shown in Figure 8. Both data sets are 
normalised to 100% at 0°. The azimuth data were taken using the cylindrical insert as shown in Figure 
4. Determination of the angle for this phantom has a Type A uncertainty of 2.5°. The polar data were 
taken using the phantom shown in Figure 5. As the source was driven by the HDR loader to set points 
with 1 mm accuracy, the estimated uncertainty is calculated to be 0.6°. Type A uncertainty in 325 
response in both sets is ±0.8% (1 standard deviation), mainly due to electronic noise associated with 
using a single detector on a kapton tail and is obtained by repeated measurements.  
 
Figure 8 - The angular response of the epitaxial diode (Polar and Azimuth). 
Both data sets show a variation in response of the diode of 15% between the top face (0°) and bottom 330 
face (180°) of the epitaxial detector but it is uniform within ±5% of variation for angles range of 
0±60° and 180±60°. Data measured in the polar direction between 0-110° were excluded due to issues 
in alignment resulting in aberrant values. The obtained angular response in Figure 8 is used in 
modifying the dose response of each detector used within the iterative algorithm for seed position 
identification. The regions of flat angular response can be used for better accuracy of seed 335 
reconstruction algorithm and is corresponding to situation when closest diodes neighbourhood is used 
as in a presented algorithm.  
There is an asymmetrical boundary region surrounding the sensitive volume, made up of silicon 
where charge collection is not ideal, leading to a lower amount of charge collected per detected event 
in this part of the sensitive volume. The structure of the detector, in conjunction with the energy 340 
dependence of the response of silicon for the 192Ir source and attenuation of secondary particles 
through the passive silicon, is the cause of the observed variation of the response30. 
IV.B. Source-to-Detector Distance Dose Measurements 
The SDD dose response of the MP to a 192Ir source in a water equivalent plastic phantom was 
measured using the central element of the detector array. The source was positioned directly over the 345 
sensor at the initial SDD of 6 mm from the central detector and then varied to 71 mm. The type B 
uncertainty associated with the alignment in the z plane was estimated as large as ±1 mm. 
Measurements over 71 mm were not obtainable by the current readout system due to signal being 
below the measurable threshold. 
Based on the TG-43 Protocol, a calculation of the radial dose function was performed using the MP 350 
SDD dose response, taking into the account the estimated radial distance and the 192Ir source physical 
dimensions, shown in Figure 9. This calculation takes into account the 1/r2 dependence and allows for 
deviations from the theoretical to be clearly seen. The large uncertainties shown within the figure at 
low SDDs are due to the combination of the uncertainty of the repeated measurements and the large 
percentage error from using a 1 mm positioning uncertainty.  355 
 
Figure 9 - Comparison between the radial dose function, g(r) for 192Ir from the TG-43 protocol and that based upon the MP 
response. 
Deviations from expected response are seen at source-to-detector distance over 15 mm. The measured 
followed the TG-43 calculated radial dose function up to 30 mm within 8% and for 70 mm within 360 
40%, respectively. This is due to a possible over response of the silicon detector at these SDDs due to 
a larger lower energy scatter contribution31. Although there is a differing response of MP compared to 
the TG-43 protocol, it does not interfere with the source position determination accuracy proposed in 
this work. 
IV.C. Evaluation of HDR Source Tracking 365 
Comparison of the positions and dwell times determined by the HDR source tracking algorithm and 
those inputted into the Nucletron microSelectron HDR afterloader computer show good agreement for 
the MP SDD of 10 mm as seen in Figure 10. Dwell times are all measured to be 2 s, with the catheter 
position measured to be on average xs = 50.3 ± 0.1 mm and zs = 10.5 ± 0.4 mm with type A 
uncertainties calculated by 1 standard deviation.  370 
 
Figure 10 - Comparison of source tracking calculation of a HDR source of step size 2.5 mm and dwell time of 2 seconds 
against expected prescribed position (zs = 10 mm) 
It is also possible to see a slight drop in expected position at the start of the dwell times. This is due to 
the source being measured in transit between dwell positions with an acquisition speed of 100 ms. 375 
Using a faster acquisition frequency, it is possible to accurately measure the source in transit, and 
determine the source transit time.  
 
Figure 11 - Frequency histogram showing the difference in the prescribed position and that measured using the MP source 
tracking algorithm for the described treatment plan. 380 
Figure 11 shows the frequency distribution of the difference between the prescribed position and the 
measured position of the HDR source with approximately 75% of measurements falling within 0.5 
mm. The occurrences of the larger differences are due to the source in transit. This result 
demonstrates the feasibility to track the HDR source in real time, accurately, over a wide field of view 
of MP (10x10 cm2).  385 
IV.D. High Speed HDR Source Tracking using X-Tream System 
Figure 12 shows the temporal response of the single epitaxial diode using the X-Tream acquisition 
system. The HDR source moves through the catheter to the first dwell position, where it is stationary 
for 5 seconds, then moves 15 mm to the final dwell position, and is motionless for an additional 5 
seconds. The source finally retracts back into the afterloader after this time. An increase in response 390 
can be seen as the second dwell position is closer to the detector. Measurements were taken over 16 
seconds, at 1 MHz sampling rate; data has been averaged by a factor of 10 to improve the signal to 
noise ratio on the measurements and to make data handling and processing easier. Standard deviations 
of the average system response for one measurement in the first and second dwell positions are found 
to be 3.9% and 1.9%, respectively. 395 
  
Figure 12 - Temporal response of epitaxial diode due to HDR source being stepped toward diode with 15 mm step size (two 
dwelling positions). 
Due to the high speed of the acquisition system, there are approximately 5000 samples when 
measuring the HDR source in transit, as seen in Figure 13. The source transit time was measured as 400 
the time interval between the two events when the detector response is changing more than one 
standard deviation above the average response at the two consecutive dwell position, to when the 
source reaches the average value of response of the second dwell position, thus giving an average 
speed for a 15 mm step size. The average transit speed was evaluated as a function of step size in the 
range between 2.5 and 50 mm for 3 measurements per step size.  405 
 
Figure 13 - Magnified view of averaged response due to HDR source movement between dwell positions for a 15 mm step 
size. 
The results are shown in Figure 14, along with values published. The type A uncertainty of each result 
is less than 5% and is calculated based on the standard deviation of the average speed of three 410 
measurements per step size. Values found within the literature have a large variation, showing the 
challenging nature of this characterisation. Measurements performed by Sahoo27 using an Ion 
chamber recorded up to 100% uncertainty due to the poor timing resolution of the system. The X-
Tream measurement shows good agreement with the measurements performed by a direct estimation 
of the transit time in Houdek et al29, which was performed using an oscilloscope to measure the pulse 415 
generator of the stepping motor of the afterloader; also the data from Wong et al28 obtained by the use 
of a high speed camera shows good agreement. Minamisawa et al13 used an optical fibre system to 
detect the radiation generated by the moving HDR source to calculate the instantaneous and average 
velocity. 
Although the discrepancy of absolute value is related to the specific afterloader, this direct 420 
measurement technique show similar dependence of the source velocity with the step size. The large 
volume of the detector and indirect estimation of the speed lead to significant errors and uncertainty 
especially for short dwell distances in this method.  
 
Figure 14 - Average transit speed measured using X-Tream System (black). Results extracted from the literature are shown 425 
for comparison. 
Although there is good agreement with previous results, the use of a single detector is not 
recommended for an accurate evaluation of the source speed as only average source speed is 
measured. Using the MP array, with its constant detector spacing and a sampling rate of 100 µs, 
instantaneous speed measurements could be performed for any positions within treatment related 430 
volume, similar to the method proposed by Minamisawa et al13, which uses an optical fibre system 
and digital oscilloscope with timing resolution of 1 nanosecond. 
V. Conclusion 
The MP detectors, detector array and readout electronics, designed originally for use in IMRT and 
VMAT radiotherapy quality assurance, were characterised for their use in fast HDR QA. The 435 
developed epitaxial diodes, which are attractive due to their radiation hardness and high stability, 
were characterised in terms of measured dose and angular responses using the 192Ir HDR source. 
Further development will allow for reliable measurements at larger distances, necessary for future in-
vivo source tracking applications and in-vivo dosimetry based on known location of the source, 
relative to anatomy.  440 
Based on the detailed characterisation of “Magic Phantom” for QA in HDR brachytherapy using 192Ir 
HDR source, the selection of the distance between MP and upper and lower planes of catheters 5-10 
mm away ensures the accuracy of the iterative method. The “Magic Phantom” for QA in HDR 
brachytherapy will verify the correctness of the plan delivery, catheter by catheter in terms of 
dwelling position and time, and will help to avoid accidents associated with the malfunction of the 445 
afterloader. A comparison of the “Magic Phantom” and selected devices from the literature for HDR 
quality assurance is presented in Table 1. 
Table 1 - Comparison of "Magic Phantom" with selected systems found with literature. 






Can test full 
treatment plan? 
- Yes, currently up 
to 20 catheters. 
- Yes, but only one 
catheter per test. 
Not in real time  
- Tested with 3 
catheters only 





- 75% of source 
positions were 
measured within 
0.5 mm of expected 
position and in real 
time. 
- 0.5 mm by manual 
inspection, 0.2 mm 
by digital off line 
processing. 
- 1.01 mm standard 
deviation. 
- Positional 
Markings in 1 mm 
increments. 
Can check dwell 
times? 
- Yes. - Yes. - No. - Post image 
analysis is required. 
Timing Resolution: - Currently 1 ms. - 1 ms. - Unknown - Timing resolution 
of video camera. 
Advantages: - Instant Readout of 








- Film which can be 
kept for records. 
- Exists in clinical 
setting. 
- Water equivalent 
detectors. 
- High resolution 
video recorded for 
records. 




- Needs expensive 
Film for every test. 
- Time consuming 
to verify full plan. 
- Need for post 
processing of data. 
- Limited to source 
step size >1cm. 
- Expensive device. 
 - User needs to 
watch and analyse 
video recording. 
 
 By reconstructing the source position based on directly measuring the radiation source any incorrect 450 
estimate of the source position relative to the needle tip in planning will also be immediately 
identified during QA of the treatment plan. It can be used for full plan QA or for a partial verification 
for accelerated QA for each patient plan. A developed software interface will allow for the immediate 
visualisation of results and analysis of acceptance parameters in terms of tolerance of actual dwelling 
positions and times, in comparison with the treatment plan. 455 
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